These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33079453)

  • 1. JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps.
    Dukart J; Holiga S; Rullmann M; Lanzenberger R; Hawkins PCT; Mehta MA; Hesse S; Barthel H; Sabri O; Jech R; Eickhoff SB
    Hum Brain Mapp; 2021 Feb; 42(3):555-566. PubMed ID: 33079453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal data fusion reveals functional and neurochemical correlates of Parkinson's disease.
    Shi D; Wu S; Zhuang C; Mao Y; Wang Q; Zhai H; Zhao N; Yan G; Wu R
    Neurobiol Dis; 2024 Jul; 197():106527. PubMed ID: 38740347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging advances in Parkinson's disease.
    Rispoli V; Schreglmann SR; Bhatia KP
    Curr Opin Neurol; 2018 Aug; 31(4):415-424. PubMed ID: 29878908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease.
    Ren J; Yan L; Zhou H; Pan C; Xue C; Wu J; Liu W
    Neurobiol Dis; 2023 Sep; 185():106254. PubMed ID: 37558169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
    Gan C; Cao X; Sun H; Ye S; Shi J; Shan A; Gao M; Wan C; Zhang K; Yuan Y
    Neurobiol Dis; 2024 Aug; 198():106560. PubMed ID: 38852751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling neurotransmitters impairment in primary progressive aphasias.
    Premi E; Dukart J; Mattioli I; Libri I; Pengo M; Gadola Y; Cotelli M; Manenti R; Binetti G; Gazzina S; Alberici A; Magoni M; Koch G; Gasparotti R; Padovani A; Borroni B
    Hum Brain Mapp; 2023 Apr; 44(6):2245-2253. PubMed ID: 36649260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neuroimaging in Parkinson's disease.
    Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM
    J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging of depression in Parkinson's disease: a review.
    Chagas MH; Linares IM; Garcia GJ; Hallak JE; Tumas V; Crippa JA
    Int Psychogeriatr; 2013 Dec; 25(12):1953-61. PubMed ID: 23992107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging non-dopaminergic function in Parkinson's disease.
    Brooks DJ
    Mol Imaging Biol; 2007; 9(4):217-22. PubMed ID: 17340229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging beyond the striatonigral dopaminergic system in Parkinson's disease.
    Giza E; Gotzamani-Psarrakou A; Bostantjopoulou S
    Hell J Nucl Med; 2012; 15(3):224-32. PubMed ID: 23106055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.
    Rolinski M; Griffanti L; Piccini P; Roussakis AA; Szewczyk-Krolikowski K; Menke RA; Quinnell T; Zaiwalla Z; Klein JC; Mackay CE; Hu MT
    Brain; 2016 Aug; 139(Pt 8):2224-34. PubMed ID: 27297241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging in Parkinson's Disease.
    Politis M; Pagano G; Niccolini F
    Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective neuroimaging in vivo.
    Smith DF; Jakobsen S
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):507-22. PubMed ID: 17368004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging in Parkinson's disease: the role of monoamines in behavior.
    Brooks DJ; Piccini P
    Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.
    Zou J; Weng RH; Chen ZY; Wei XB; Wang R; Chen D; Xia Y; Wang Q
    CNS Neurosci Ther; 2016 Mar; 22(3):167-77. PubMed ID: 26776081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging in Parkinson's disease.
    Stoessl AJ
    Neurotherapeutics; 2011 Jan; 8(1):72-81. PubMed ID: 21274687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional neuroimaging in Parkinson's disease.
    Niethammer M; Feigin A; Eidelberg D
    Cold Spring Harb Perspect Med; 2012 May; 2(5):a009274. PubMed ID: 22553499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging in Parkinsonian Disorders.
    Tripathi M; Kumar A; Bal C
    Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid PET-MRI Applications in Movement Disorders.
    Tondo G; Esposito M; Dervenoulas G; Wilson H; Politis M; Pagano G
    Int Rev Neurobiol; 2019; 144():211-257. PubMed ID: 30638455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.